Gender-related differences in the association between concomitant amplification of AIB1 and HER2 and clinical outcomes in glioma patients

In this study, we reveal a gender difference in the prognostic value of concomitant AIB1 and HER2 CNG in glioma patients which were barely noticed before. These observations indicated that genetic alterations synergistic with essential respects of sex determination influence glioma biology and patients outcomes.